Which drugs MFDS approved the most this year?

Published: 2017-12-07 16:29:00
Updated: 2017-12-07 13:35:17

This year, the most therapeutic category approved by the Ministry of Food and Drug Safety was anticoagulants with 6 products, and it was followed by 3 products of anticancer drugs and antihypertensives respectively.

Moreover, the only novel drug developed by a Korean pharmaceutical company was I...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean




Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.